Squarepoint Ops LLC Cuts Stock Position in Surgery Partners, Inc. $SGRY

Squarepoint Ops LLC trimmed its position in Surgery Partners, Inc. (NASDAQ:SGRY) by 74.5% during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 53,066 shares of the company’s stock after selling 154,971 shares during the period. Squarepoint Ops LLC’s holdings in Surgery Partners were worth $1,180,000 as of its most recent SEC filing.

A number of other large investors also recently bought and sold shares of the company. AlphaQuest LLC lifted its stake in shares of Surgery Partners by 112.0% in the 1st quarter. AlphaQuest LLC now owns 1,058 shares of the company’s stock worth $25,000 after acquiring an additional 559 shares during the period. PNC Financial Services Group Inc. raised its holdings in Surgery Partners by 86.4% during the first quarter. PNC Financial Services Group Inc. now owns 1,169 shares of the company’s stock worth $28,000 after purchasing an additional 542 shares in the last quarter. FNY Investment Advisers LLC acquired a new stake in Surgery Partners in the second quarter valued at about $115,000. Tower Research Capital LLC TRC boosted its holdings in Surgery Partners by 68.7% in the 2nd quarter. Tower Research Capital LLC TRC now owns 9,313 shares of the company’s stock valued at $207,000 after purchasing an additional 3,794 shares in the last quarter. Finally, Prudential Financial Inc. acquired a new position in Surgery Partners during the 2nd quarter worth approximately $219,000.

Surgery Partners Stock Down 0.8%

Surgery Partners stock opened at $15.70 on Friday. Surgery Partners, Inc. has a fifty-two week low of $14.94 and a fifty-two week high of $26.16. The firm has a market capitalization of $2.03 billion, a price-to-earnings ratio of -11.54 and a beta of 1.93. The stock’s fifty day moving average is $18.38 and its two-hundred day moving average is $20.79. The company has a debt-to-equity ratio of 1.10, a quick ratio of 1.72 and a current ratio of 1.88.

Surgery Partners (NASDAQ:SGRY) last released its quarterly earnings results on Monday, November 10th. The company reported $0.13 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.19 by ($0.06). The firm had revenue of $821.50 million for the quarter, compared to analyst estimates of $823.55 million. Surgery Partners had a positive return on equity of 2.41% and a negative net margin of 5.21%.The company’s quarterly revenue was up 6.6% compared to the same quarter last year. During the same period last year, the firm earned $0.19 EPS. Analysts predict that Surgery Partners, Inc. will post 0.67 EPS for the current fiscal year.

Analysts Set New Price Targets

Several analysts have recently commented on SGRY shares. Barclays reduced their price target on Surgery Partners from $24.00 to $18.00 and set an “equal weight” rating for the company in a report on Friday, November 21st. Cantor Fitzgerald reissued an “overweight” rating and issued a $36.00 target price on shares of Surgery Partners in a report on Tuesday, October 7th. Mizuho decreased their target price on shares of Surgery Partners from $22.00 to $19.00 and set an “outperform” rating on the stock in a research report on Thursday. JPMorgan Chase & Co. cut their price target on shares of Surgery Partners from $27.00 to $20.00 and set a “neutral” rating for the company in a report on Monday, November 24th. Finally, Benchmark reduced their price objective on shares of Surgery Partners from $35.00 to $30.00 and set a “buy” rating for the company in a research note on Tuesday, November 11th. Seven investment analysts have rated the stock with a Buy rating, two have given a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $27.11.

About Surgery Partners

Surgery Partners, Inc operates as a healthcare services provider specializing in the management and ownership of ambulatory surgery centers, surgical hospitals and multispecialty rehabilitation hospitals across the United States. Through its network of facilities, the company coordinates and delivers a broad range of outpatient surgical procedures in specialties such as orthopedics, ophthalmology, otolaryngology, gastroenterology, pain management and general surgery. Its integrated platform offers ancillary services including on-site imaging, laboratory testing, infusion therapy and physical, occupational and speech rehabilitation.

Since its establishment in 2010 and subsequent public listing in 2015, Surgery Partners has focused on strategic partnerships with physicians and health systems to expand access to cost-effective outpatient care.